This class of molecules, known for their PDE5 inhibitoryactivity, showed in vitro anti-AD effects on humanrecombinant BACE-1 inhibition assay and increased the activity ofP-gp ATPase, with a possible role in the efflux of Aβ acrossthe BBB.122,130. Here, PDE5A is linked to Alzheimer disease.